Agenzia Italiana del Farmaco Home
Asset Publisher
30/11/2020
Monitoring Registers
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
26/11/2020
COVID-19 emergency
The Italian Medicines Agency published an update, based on the most recent studies, of the fact sheets relating to the use of hydroxychloroquine, remdesivir and heparin for the treatment of COVID-19 patients.
20/11/2020
Press corner
Dichiarazione del Direttore Generale dell’AIFA Nicola Magrini su vaccino anti Covid-19
16/11/2020
Safety of medicinal products
EMA’s human medicines committee (CHMP) has started a ‘rolling review’ of data on a vaccine for COVID-19 known as mRNA-1273, which is being developed by Moderna Biotech Spain, S.L. (a subsidiary of Moderna, Inc.).
23/11/2020
AIFA Focus
AIFA Focus
AIFA data
AIFA data
GMP inspections (API and medicinal products) 2019
